title: The size of clinical trials in cancer research--what are the current needs? Medical Research Council Cancer Therapy Committee.
abstract: Most randomised clinical trials of cancer treatment include a few hundred patients or less. Recent statistical papers advocate that sometimes thousands of patients should be entered. In this paper I show that for certain types of cancer trials the 'thousands policy' is not required while for others it is desirable but not feasible. In the latter case other strategies should be considered, such as two-stage phase III studies or parallel studies leading to overviews. There is, however, an important subset of trials for which application of the thousands policy is both necessary and feasible. The key to progress lies partly in the achievement of greater recruitment rates in trails of common cancers and partly in greater inter-group collaboration.
authors.affiliation: MRC Cancer Trials Office, Cambridge, UK.
authors.forename: L S
authors.initials: LS
authors.lastname: Freedman
mesh_terms: D002986:Clinical Trials as Topic / Q000639:trends*; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D013223:Statistics as Topic